Pall Corporation

Virtual Meet The Experts Seminar

Discover New Technologies

Pall Freeze & Go Solutions
Safe Handling of Biologics From Bulk Manufacturing To Fill and Finish

In-depth virtual seminar customized to your needs
including a virtual facility tour​ 

Date:
Customized to your schedule
Duration: 60-90 Minutes     
Platform: Microsoft Teams

Safe handling of bulk drug substance between downstream and fill & finish can be challenging. Pall provides an enhanced end-to-end solution to fill, freeze, transport and thaw bulk drug substance.​ Allegro™ biocontainers are protected at all times by the unique RoSS♦ shell concept. The complete immobilization throughout the validated workflow enables fast and flexible automated bulk filling, controlled freezing, safe transportation and controlled thawing to protect against leakage and product loss. The technology is scalable and ensures identical freezing kinetics from early clinical trials up to commercial manufacturing.​

Join our experts and learn more how to minimize leakage and product loss with Pall® Freeze & Go Solutions.​

Watch Freeze & Go Solutions Video

The event includes a virtual facility tour with a short demo of the equipment

Please note: The agenda can be modified according to YOUR individual needs.

  • Allegro Single-Use Systems - Quality by Design

  • Pall Freeze & Go Solutions - Protected By RoSS Technology

  • Virtual Factory Tour, Kufstein, Austria

  • 1:50pm

    Upstream technologies to industrialize gene therapy

    TBD

  • 2:40pm

    Break

  • 2:45pm

    Keynote

    TBD

  • 3:45pm

    Case study 1: Molmed’s implementation of iCELLis technology for lentiviral production

    TBD

  • 4:15pm

    Case study 2: Cost modelling of upstream production for Lentivirus

    TBD

  • 4:45pm

    Case study 3: End-to-end manufacturing of adenovirus

    TBD

  • 5:15pm

    Party

  • 1:00pm

    Company profile of Pall Biotech

    TBC

  • 1:10pm

    Company profile of Molmed

    TBD

  • 1:20pm

    Industrializing Gene Therapy

    TBD

  • 1:50pm

    Upstream technologies to industrialize gene therapy

    TBD

  • 2:40pm

    Break

  • 2:45pm

    Keynote

    TBD

  • 3:45pm

    Case study 1: Molmed’s implementation of iCELLis technology for lentiviral production

    TBD

  • 4:15pm

    Case study 2: Cost modelling of upstream production for Lentivirus

    TBD

  • 4:45pm

    Case study 3: End-to-end manufacturing of adenovirus

    TBD

Registration Form

If you would like to book your Virtual Meet the Experts Seminar, please complete the form below and click the “Send Confirmation” button.